Eric S. Halsey

Infectious Disease

550 Peachtree Street Northeast
MedicalOfficeTower
Atlanta, GA 30308

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

A Book for Medical Device Patents.

A Book for Medical Device Patents.

Journal: JAMA

Published: June 15, 2026

Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data.

Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 27, 2026

Costs of typhoid vaccination for international travelers from the United States.

Costs of typhoid vaccination for international travelers from the United States.

Journal: Travel medicine and infectious disease

Published: November 12, 2024

Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment.

Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment.

Journal: Malaria journal

Published: July 05, 2024

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.

Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.

Journal: Malaria journal

Published: January 18, 2024

Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection.

Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection.

Journal: Journal of travel medicine

Published: November 03, 2023

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.

Journal: The American journal of tropical medicine and hygiene

Published: July 26, 2022

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting.

Journal: The American journal of tropical medicine and hygiene

Published: July 26, 2022

STARTER checklist for antimalarial therapeutic efficacy reporting.

STARTER checklist for antimalarial therapeutic efficacy reporting.

Journal: Malaria journal

Published: June 13, 2022

Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia, Kenya, Madagascar, and Rwanda.

Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions from Persons with Symptomatic Malaria Infection in Ethiopia, Kenya, Madagascar, and Rwanda.

Journal: Emerging infectious diseases

Published: February 24, 2022

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.

Journal: Malaria journal

Published: February 08, 2022

Symptomatic Plasmodium vivax Infection in Rwanda.

Symptomatic Plasmodium vivax Infection in Rwanda.

Journal: Open forum infectious diseases

Published: October 21, 2021

Showing 1-12 of 111

Last Updated: 09/26/2026